Hem › Bukspottkörtelcancer › Washington › Seattle
Kliniska studier för Bukspottkörtelcancer i Seattle, WA
21 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Seattle (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekryterarFas 3
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- Swedish Cancer Institute, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekryterarObservationsstudie
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 3
- Fred Hutchison Cancer Center, Seattle
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US032, Seattle
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekryterarFas 3
- Virginia Mason Franciscan Health - Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center - Advanced Cancer Research Group, Seattle
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekryterarFas 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekryterarFas 2
- Local Institution - 0086, Seattle
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekryterarFas 2
- Virginia Mason, Seattle
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 1
- Virginia Mason Medical Center, Seattle
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekryterarFas 1
- Fred Hutchinson Cancer Center, Seattle
Pancreatic Cancer Early Detection Consortium
RekryterarObservationsstudieFriska volontärer välkomna
- University of Washington, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekryterarFas 1/2
- Fred Hutchinson Cancer Center, Seattle
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekryterarFas 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- och 3 fler
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekryterarFas 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekryterarFas 1/2
- Virginia Mason Medical Center, Seattle
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Seattle
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Seattle
- Icke-småcellig lungcancer53 studier
- Cancer (alla typer)49 studier
- Prostatacancer42 studier
- Akut myeloid leukemi41 studier
- Bröstcancer39 studier
- Metastaserande cancer39 studier
- Kolorektal cancer34 studier
- Lungcancer33 studier
- Äggstockscancer30 studier
- Multipelt myelom22 studier
- Blåscancer21 studier
- Myelodysplastiska syndrom21 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.